![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
March 30, 2026
The latest findings in breast cancer, cancer care delivery research, head and neck cancer, leukemia, and radiation therapy
February 27, 2026
The latest clinical trial findings in breast cancer, leukemia, lymphoma, lung cancer, NCI-MATCH, and prostate cancer
January 30, 2026
10 cancer research discoveries in 2025 by ECOG-ACRIN and PrECOG that captured attention across the scientific and patient advocacy communities
January 30, 2026
The latest research in breast cancer, geriatric oncology, leukemia, NCI-MATCH, and symptom management
December 19, 2025
Blood and breast cancer research highlights from the 67th American Society of Hematology Annual Meeting and Exposition, and the San Antonio Breast Cancer Symposium
November 21, 2025
Timely information about research presented at medical meetings, recognition of research leaders, and more
August 28, 2025
The latest clinical trial findings in breast cancer, leukemia, NCI-MATCH precision medicine, penile cancer, and prostate cancer
July 10, 2025
Timely information about research presented at medical meetings, recognition of research leaders, and more
June 11, 2025
The changes broaden eligibility and clarify treatment planning details in this phase 2 trial testing daratumumab-hyaluronidase to eliminate minimal residual disease after initial chemotherapy
March 21, 2025
Summaries of recently published ECOG-ACRIN and PrECOG research results
March 21, 2025
Summaries and links to timely information about research results presented at medical meetings, recognition of research leaders, and more
February 19, 2025
Seven ground-breaking findings from cancer clinical trials in 2024 by ECOG-ACRIN and PrECOG